Discussion Topic:Â Asundexian versus Apixaban in Patients with Atrial Fibrillation
Join moderator Melissa Middeldorp as she discusses the NEJM article Asundexian versus Apixaban in Patients with Atrial Fibrillation with Christopher C Cheung, MD, MPH and Prashanthan Sanders, MBBS, PhD, FHRS at HRS2024 in Atalnta. Brought to you live from the HRSTV Studio, this episode comes with bonus video footage.
Host:Â Melissa E. Middeldorp, MPH, PhD
Guests:Â Christopher C Cheung, MD, MPH and Prashanthan Sanders, MBBS, PhD, FHRS
Speaker and Article Information:Â Download
**View bonus video footage from HRX 2024 in Atlanta while listening on HRS365!
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 143: A Discussion of The Empirical Evidence in the Successful Anatomical Ablation of Idiopathic LV Summit Ventricular Arrhythmias
In this discussion, Dr. Deep Chandh Raja, MBBS, MD, PhD, is joined…
April 9, 2026
The Lead
Podcasts
The Lead Episode 142: A Discussion of Class 1c Antiarrhythmic Therapy Following PCI in New Onset Atrial Fibrillation: Safety and Clinical Outcomes from a Nationwide Cohort
Join an expert-led discussion exploring the safety and clinical outcomes of Class…
April 2, 2026
The Lead
Podcasts
The Lead Episode 141: A Discussion of Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis
Join Digital Education Committee member and podcast host Melissa E. Middeldorp, MPH,…
March 19, 2026